Leif W. Ellisen

Also affiliated with Harvard University Press, Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Center for Cancer Research

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma”.

A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma

Nature Metabolism(2021)10.1038/s42255-021-00350-6

N/A

1.7DataRank · unranked

48 citations

Carlos Sebastián, Christina M. Ferrer, Caroline A. Lewis, Moshe Sade-Feldman, Thomas J. LaSalle +19 more

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0702

N/A

0.818DataRank · unranked

233 citations

Sheng Sun, Ignaty Leshchiner, Nayana Thimmiah, Elizabeth E. Martin, Daniel E. McLoughlin +17 more

Sequential use of antibody-drug conjugate after antibody-drug conjugate for patients with metastatic breast cancer: ADC after ADC (A3) study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1022

N/A

0.604DataRank · unranked

55 citations

Laura M. Spring, Geoffrey Fell, Phoebe Ryan, Neelima Vidula, Arielle J. Medford +8 more

TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2771

N/A

0.574DataRank · unranked

45 citations

Bogang Wu, Haley Barnes, Arielle J. Medford, Bryanna L. Norden, Annika Putur +16 more

Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0638

N/A

0.483DataRank · unranked

24 citations

Taronish D. Dubash, Michael S. Lawrence, Antoine Simoneau, Andrzej Niemierko, Erica Blouch +24 more

A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression

JCO Precision Oncology(2023)10.1200/po.22.00532

N/A

0.425DataRank · unranked

16 citations

Taronish D. Dubash, Gabriela N. Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S.L. Kim +27 more

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

EBioMedicine(2025)10.1016/j.ebiom.2025.105828

N/A

0.404DataRank · unranked

7 citations

Rosario Chica-Parrado, Caroline Weipert, Todd C. Knepper, Emily Podany, Fabiana Napolitano +21 more

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.02.626446

N/A

0.269DataRank · unranked

5 citations

Win Thant, Elena Bitman, Ting Liu, Jie Liu, Eleftherios I. Paschalis +17 more

Regulation of RNA methylation by therapy treatment, promotes tumor survival

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.19.540602

N/A

0.165DataRank · unranked

2 citations

Samuel S. Truesdell, Chandreyee Datta, Pritha Choudhury, Keith Q. Wu, Jitendra Shrestha +14 more

Data from Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6517369.v1

N/A

0DataRank · unranked

0 citations

Anthony C. Nichols, Edmund A. Mroz, William C. Faquin, John R. Clark, Shahnaz Begum +6 more

Association of pretreatment chest CT abnormalities with trastuzumab deruxtecan–associated pneumonitis.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1106

N/A

0DataRank · unranked

0 citations

Zachary Hartley-Blossom, Geoffrey Fell, Phoebe Ryan, Erika Nakajima, Beverly Moy +5 more

Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair

Nature Communications(2024)10.1038/s41467-024-45693-2

N/A

0DataRank · unranked

19 citations

Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang +19 more

Revisiting Androgen Receptor Signaling in Breast Cancer

The Oncologist(2023)10.1093/oncolo/oyad049

N/A

0DataRank · unranked

38 citations

Leif W. Ellisen, Charles S. Dai

Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair

Nature Communications(2024)10.1038/s41467-024-48241-0

N/A

0DataRank · unranked

0 citations

Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang +19 more

Mechanisms of Resistance to Antibody–Drug Conjugates

Cancers(2023)10.3390/cancers15041278

N/A

0DataRank · unranked

140 citations

Bogang Wu, Laura M. Spring, Leif W. Ellisen, Aditya Bardia, Rachel O. Abelman

An AMPK-dependent, non-canonical p53 pathway plays a key role in adipocyte metabolic reprogramming

eLife(2020)10.7554/elife.63665

N/A

0DataRank · unranked

8 citations

Xueping Wan, Paul F. Pilch, Leif W. Ellisen, Susan K. Fried, Libin Liu +1 more

Current landscape of sequencing ADCs in metastatic breast cancer

Therapeutic Advances in Medical Oncology(2025)10.1177/17588359251396656

N/A

0DataRank · unranked

4 citations

Lis V. Ravani, Beverly Moy, Arielle J. Medford, Steven J. Isakoff, Ting Liu +5 more